Veradermics (MANE) Total Liabilities (2024 - 2026)

Veradermics has reported Total Liabilities for 3 years, with the latest figure at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 88.93% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (down 88.93% YoY), and the FY2025 full-year result was $9.2 million, up 94.07% from the prior year.
• Total Liabilities for Q1 2026 stood at $6.7 million, down from $9.2 million in the prior quarter.
• The five-year high for Total Liabilities was $60.7 million in Q1 2025, with the low at $4.7 million in Q4 2024.
• Historically, Total Liabilities has averaged $20.3 million across 3 years, with a median of $7.9 million in 2025.
• Annual changes were most pronounced in 2025 — Total Liabilities jumped 94.07% — and 2026, when it tumbled 88.93%.
• Veradermics' Total Liabilities stood at $4.7 million in 2024, then jumped by 94.07% to $9.2 million in 2025, then declined by 26.65% to $6.7 million in 2026.
• The last three Total Liabilities figures came in at $6.7 million (Q1 2026), $9.2 million (Q4 2025), and $60.7 million (Q1 2025), per Business Quant data.